Aurinia Pharmaceuticals to Release Fourth Quarter and Year End 2020 Financial Results on February 24, 2021 Biotech Investing
Pfizer and BioNTech to Supply the European Union with 200 Million Additional Doses of COMIRNATY® Pharmaceutical Investing
Gilead Sciences and Wake Forest University School of Divinity Partner to Address HIV Epidemic Through Faith-Based Programming and Community Outreach Biotech Investing
Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers Medical Device Investing
KEYTRUDA® Plus LENVIMA® Demonstrated Superior Progression-Free Survival and Overall Survival Versus Sunitinib as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma Pharmaceutical Investing
U.S. FDA Approves PANZYGA® for the Treatment of Adults with Chronic Inflammatory Demyelinating Polyneuropathy Pharmaceutical Investing
Kite Announces New ZUMA-1 Cohort Analysis Evaluating Prophylactic Corticosteroid Use With Yescarta® in Patients With Relapsed or Refractory Large B-cell lymphoma Biotech Investing
Jamieson Wellness Inc. Announces Date of Fourth Quarter and Full Year 2020 Financial Results and Conference Call Pharmaceutical Investing
Seegnal Inc. Receives Gold Mark from the Standards Institution of Israel, Advancing Commercialization Readiness
